The Union Budget 2026 signals a strong shift—positioning India beyond generics toward global leadership in biologics and advanced therapies.
With increased investments in innovation and infrastructure, the Indian pharma industry is poised for accelerated global growth.
Hab Pharma is proud to be part of this evolving ecosystem, delivering quality-driven pharmaceutical solutions.